Avita Medical Inc【RCEL】株式ニュース

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDermCohealyx...

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

VALENCIA, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

VALENCIA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a company...

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical Reports Third Quarter Financial Results

VALENCIA, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical to Announce Third Quarter 2024 Financial Results

VALENCIA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

VALENCIA, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference

VALENCIA, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

Form S-8 - Securities to be offered to employees in employee benefit plans

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical Reports Second Quarter Financial Results

VALENCIA, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales

VALENCIA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

Form 8-K - Current report

AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care

VALENCIA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a...

pick 3月前

This happened in my backyard. I live near Powhatan and read of the fire. (There are a lot of horse farms around here; Powhatan and Chesterfield counties, where I live are suburds of Richmond, where VCU is located. VCU Hospital was formerly known as the Medical College of Virginia)

It's good PR for Avita, and the widespread used of Recell.

👍️0

Fmello 4月前

Medical director uses new technology to save horse’s skin after massive barn fire

https://www.12onyourside.com/2024/08/02/medical-director-uses-new-technology-save-horses-skin-after-massive-barn-fire/

👍️0

Spetch 5月前

Hi guys, what the hell just happened? We come out with a new product and it drops 10%.

👍️0

Spetch 5月前

Come on bod
Let’s see you put some money where your mouth is As this long-term drop is ridiculous

👍️0

Dretired 6月前

These individual news story need to be developed in all the metropolitan areas throughout the country.

👍️0

Dretired 6月前

Yes good reference post.

👍️0

Spetch 6月前

Hi guys
Would be nice to see some of the board put some money into this would show confidence in the new product
What are your thoughts?

RECELL Go Gets FDA Approval

Massive!!

THIS IS THE WAY.

https://ir.avitamedical.com/news-releases/news-release-details/avita-medical-announces-fda-approval-recell-go

👍️0

believeinsteven 7月前

Morningstar: Avita Medical Shares Remain Undervalued, With Long-Term Opportunity Intact

👍️ 1

Trueheart 7月前

Gratifying? It's my best guess that you're the type that drives by horrible traffic accidents, slowing down to view the carnage, the blood and mangled bodies, just so's you can have something to say that will distract your wife from her crossword puzzle as you're eating dinner.
Be a mensch!

Trueheart

👍️0

Spetch 8月前

Hi all
Would be nice to see the directors making some share buys at these low prices to show confidence in the future

👍️0

Fmello 8月前

https://www.ktnv.com/news/unique-burn-treatment-helps-logandale-girl-recover-nearly-scar-free-at-las-vegas-hospital

As I stated, how he opines is immaterial (despite the fact that he’s on record for liking the company, which is why he had Perry on twice and talked about liking the product many times thereafter). But that was a long time ago. Though positive sentiment never hurts, his “OPINEion” is largely immaterial in the scheme of the facts: FDA approvals, broadening scope, increasing sales, plenty of cash, halo product, and a path to profitability, to mention a few.

And, yes, he does do quite intensive research. He may be wacky, but he’s extremely thorough and highly intelligent. Both he and CNBC have extensive resources and staff that do serious due diligence. I assure you he will see what we ALL see. And he will like A LOT. Maybe all of it. But yes, in the final analysis, he may hedge because of the market cap. Or because they’re not yet profitable though that’s not an intransigent sentiment with him. He mainly holds that position in a risk-off environment with recessionary risk or looming rate hikes as we’ve been in the last couple years.

But these days are different. Have you seen Bitcoin lately? Upcoming IPOs? Anticipated rate cuts? We’re in a very different market than a few months ago and he may change his tune, especially when this company will be profitable by next year. Or he may not. Doesn’t really matter.

No — this is ALL about visibility. Institutions are very well aware of this stock with a couple having taken deep bites, but the retail investor by and a large? I don’t know. This stock is/was mostly held by retail last I checked, but that doesn’t necessarily indicate plurality. Many may have it off their radars these days. Many may just need a couple of positive comments that piques their interest and jives with their risk tolerance. This is who I would expect to come looking. Thousands will look. Some will buy. Maybe small fish. Maybe big fish. There’s no way to know. All I’m saying is “hold on tight.” TiGETTY-tight.

PS: relying “on the new executives executing what seems like a very workable strategy” is in no way shape or form mutually exclusive to gaining massive visibility. Both can be had.

👍️0

MONYMAN3 10月前

I'm afraid he may not opine positively. You know he doesn't recommend stocks that aren't making money? Also, as you say, market cap may not be big enough. If he really did intensive research, I believe he would come out with a positive recommendation. If anything, that would give us a short term pop. Better to rely on the new executives executing what seems like a very workable strategy.

👍️0

Cake10 10月前

Mad Money episode tonight 2/29/24 … on Leap Day of all days.

Caller: Cramer what do you think about Avita Medical?

Cramer: I do not know this company! I will have to do some work.

First of all, the question surprised me. Second, I was surprised they allowed the call to go through as the show, I believe, requires a company to have a minimum market cap of $1B or $1.5B for it to be discussed. He had Mike Perry ON his show twice (once in person) around 2019 or 2020 during its huge run up toward all-time highs when it was around that market cap. He will definitely remember once his staff does their due diligence. This is a FAR more advanced company than it was then.

Usually (maybe always) he’ll do a follow-up with his “homework” updating viewers on questions about stocks on which he was stumped by callers.

This should be VERY interesting, not necessarily because of what he does/doesn’t have to say (you should rely on your own research), but for the mere fact that he has a massive audience and massive platform for visibility.

Hold on VERY tightly to your shares until if/that segment airs, potentially within the next few weeks.

👍️ 1

artfulife 10月前

Feb 29 (Reuters) - AVITA Medical Inc(RCEL):

* AVITA MEDICAL SUBMITS RESPONSE TO FDA, RESUMING REVIEW CLOCK FOR RECELL GO PMA SUPPLEMENT

* AVITA MEDICAL INC(RCEL) - EXPECT FDA APPROVAL ON MAY 30, 2024, POSITIONING US FOR A PRODUCT LAUNCH ON MAY 31, 2024

Yes!

👍️0

MONYMAN3 10月前

https://ir.enovix.com/events/event-details/journey-scale-podcast-feb-2024-fab2-updates-coo-ajay-marathe

👍️0

MONYMAN3 11月前

https://seekingalpha.com/news/4056668-cantor-picks-rcel-as-best-2024-medtech-idea-bullish-on-pacb-axgn-cers

The Aussie stock closed up 12.59% tonight.

👍️0

Fmello 11月前

https://www-presseportal-de.translate.goog/pm/167421/5687690?_x_tr_sl=de&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

PMI CEO Christian Planck: "We are very pleased that we can now offer RECELL ® in Germany, Austria and Switzerland. Our customers have been asking about this technology for years. In fact, it is a perfect addition to our own portfolio the one- stop shop technology."

"Our partnership with PolyMedics Innovations is the first step in our strategic global expansion," said Jim Corbett, Chief Executive Officer of AVITA Medical. "PMI's proven track record and expertise in the global distribution of innovative wound treatments make them an ideal partner. We look forward to a successful collaboration that will enable us to reach more patients worldwide."

👍️0

MONYMAN3 1年前

https://us02web.zoom.us/rec/play/D_NT2rl2dZcpc7L_XUt6VJh81E_HIM21mngBXR6KjZHRPs0VCBfzNWiyCOb7vHVaubUpQSvF7WhSZaPB.oSXXXZT66WOzvHuC?hasValidToken=false&canPlayFromShare=true&from=share_recording_detail&continueMode=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fus02web.zoom.us%2Frec%2Fshare%2FDh9UFDWQhFjYF0S9afouXwsCKphzVngmXyS6lDfdDuXYk52XXdCrVctLIq0WiYkA.PO58b8CAaqc_JBTL RCEL Investor Webinar

👍️0

Fmello 1年前

Here's a detailed presentation about Recell.
(warning: some of the pics are very graphic)

https://avitamedical.showpad.com/share/NAPlEVouN92Enz79yKX4z

👍️0

believeinsteven 1年前

“We have achieved significant commercial revenue growth rates for
the last three quarters of 40%, 42% and 51%, respectively, over the
same periods in the previous year,” said David O’Toole, Chief
Financial Officer of AVITA Medical. “Further, we remain confident
that our cash reserves position us to achieve our goals and reach
profitability in 2025.”

👍️0

Spetch 1年前

Hi
Not the worst results ever moving forward

👍️0

artfulife 1年前

He's just making the rounds with another "told you so" post. 🎱🦨 😄

👍️0

Windbag1014 1年前

You're back.
Pull all the wings off the flies? Lots of legless grasshoppers in your neighborhood. No dead people to pick on? Oh the gratification.

👍️0

bar1080 1年前

Gratifying watching much "Perpetual Startup" crap collapsing. Thinking of Plug Power, LWLG (Lightwave Logic), SolarWindow, Liquidmetal.... and maybe several hundred more. This market rewards large caps with audited profits and regular cash dividends. Bad news for IHUB and its dead stock boards and company insiders drawing monstrously large wages for running itty bitty penny stocks where success is always "just around the corner."

Also: "Wow, I see this board is >ten years old. I don't buy tiny biomed stocks. Most are perpetual startups. Vapor. I require GAAP profits and usually dividends.
But I make money with my investments." https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171926857

👍️0

Spetch 1年前

Why the total free fall of share price
Any comments
Thanks steve

👍️0

Align 1年前

Apologies, it looks like I was wrong about preliminary results.

👍️0

Align 1年前

After listening to what the CEO had to say about sales momentum during two conferences in September, preliminary results and revenue guidance upgrades are possible this week in my view.

The next scheduled event after that is the earnings call and investor briefing in November where they’ll be providing earnings results, strategies on future expansions and hopefully additional commentary on the revised expectations on Recell Go approval.

👍️0

Spetch 1年前

Hi
Any idea next event that could turn share price around
Fall was to much for what is short delay in terms of things

👍️0

Fmello 1年前

That drop seems pretty excessive.

👍️0

Spetch 1年前

So over reaction by market

👍️0

Windbag1014 1年前

As previously disclosed, on June 30, 2023, AVITA Medical, Inc. (the
“Company”) submitted a premarket approval supplement application
(the “PMA”) to the U.S. Food and Drug Administration (the “FDA”)
for its latest device, RECELL GO™. The submission initiated a
prioritized, interactive review of the PMA under the FDA’s
Breakthrough Device program, which follows a 180-day review
cycle.

At the halfway point of the process, the Company received notice
from the FDA that additional information regarding the PMA is
required for the continuation of a substantive review. This
request, which is not unique to the Breakthrough Device Program,
places the application file on hold for approximately 4 to 6 months
while the Company addresses the FDA's questions. Upon the Company’s
submission of a complete response to the FDA’s request, the
application will reenter the 180-day cycle, with 90 days remaining
in the review period. This timing would imply a product launch
between May 1 and July 1, 2024.

👍️0

Spetch 1年前

I’m in the UK, so don’t quite understand what this form relates to

👍️0

Spetch 1年前

Hi chaps, can anyone explain why 20% down thank you

👍️0

Windbag1014 1年前

https://ih.advfn.com/stock-market/NASDAQ/avita-medical-RCEL/stock-news/92172037/form-8-k-current-report

👍️0

believeinsteven 1年前

What did I miss? Why the drop in share price?

👍️0

MONYMAN3 1年前

https://us02web.zoom.us/rec/play/8LuDNA4gvw9rySzh-Jq5hf2dN49r88m2nCZKTtexSjouqZawLCRgGbt1nh2P-tNaDJ8j8tVxOnNrHuwr.3HIH8zEi2s3oRXPY?hasValidToken=false&canPlayFromShare=true&from=share_recording_detail&continueMode=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fus02web.zoom.us%2Frec%2Fshare%2FgCZkGrUNe9KDQBYnXVInZRNMQ_onwfkLvCsWsFWLIoqOGkGOd6_pmcEGuJ6Lm-t4.fzvS7nm7wh5uvXdd They seem on track with the new sales personnel. I'm looking for a pretty good bump in revenues this next quarter as the new sales team pick the low hanging fruit from the hospitals that we are already in for burns. Soft tissue wounds should be a no brainer for them.

👍️0

Fmello 1年前

Here are some screenshots of the slides from today's webinar:

👍️ 1

Fmello 1年前

Avita donated Recell kits to Hawaiian burn centers to treat victims of that big wildfire.

👍️0

Fmello 1年前

The webinar just started.

👍️0

Fmello 1年前

AVITA Medical - Investor Webinar Briefing
Date & Time: Aug 15, 2023 06:00 PM central time

https://us02web.zoom.us/webinar/register/WN_QYXQA5P-TsGjPVD01tULxw#/registration

I don't mind the higher expense since I view it as an investment in the future. Sales people can reach the 20+ kit sales in as little as 3-4 months. This ramp should really ramp once we get the automated system out in the field. That RCEL GO system greatly expands the target customers from mainly hospitals down to the clinic level.

👍️0

Fmello 1年前

I wonder if BARDA's Recell stockpile will be used to treat burn victims from the Hawaiian wildfires?

👍️0

Spetch 1年前

Pos could have better loss per share though

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター